Murine AIDS: a model for the human disease or a distinct entity?

Area of Science:

• Immunology
• Virology
• Pathogenesis

Background:

• Murine immunodeficiency syndrome (MAIDS) is studied as a potential animal model for human immunodeficiency syndrome (AIDS).
• The LP-BM5 retrovirus mixture induces MAIDS in mice, prompting investigation into its pathogenic mechanisms and homology to human AIDS.

Purpose of the Study:

• To analyze recent findings on MAIDS pathogenesis.
• To discuss the implications for the proposed homology between MAIDS and human AIDS.
• To evaluate the appropriateness of the term MAIDS.

Main Methods:

• Review of existing research on LP-BM5 retrovirus infection in mice.
• Comparative analysis of MAIDS and human AIDS characteristics.
• Examination of viral etiology, genetic susceptibility, CD4+ cell dynamics, transmissibility, and in vitro spleen cell proliferation.

Main Results:

• MAIDS exhibits both similarities and distinct differences compared to human AIDS.
• Key differences include a definitive viral etiology, strong genetic influence on susceptibility, CD4+ cell expansion, and high transmissibility.
• Virus-induced spleen cell proliferation in vitro mirrors changes induced by the protein kinase inhibitor K252a.

Conclusions:

• The term MAIDS may not fully capture the distinct characteristics of the retrovirus-induced disease in mice.
• Retrovirus-induced murine lymphoproliferative disease is proposed as a more fitting descriptor.
• Further research is needed to fully elucidate the parallels and divergences between murine and human retroviral immunodeficiency syndromes.